Evolve Biologics

About

Evolve Biologics Inc. is a Canadian biopharmaceutical company founded in 2017, focused on developing and commercializing plasma-derived therapeutics. The company utilizes its proprietary PlasmaCap EBA purification technology to enhance the purity, efficiency, and yield of plasma protein extraction. Headquartered in Mississauga, Ontario, Evolve Biologics aims to meet the growing global demand for life-saving products, particularly for patients with rare diseases. The company is advancing a portfolio of plasma-derived therapeutics, including Intravenous Immunoglobulin (IVIG) for treating rare conditions and immune deficiencies, and Human Serum Albumin (HSA) for critical care applications. Evolve is constructing its first commercial manufacturing facility in Sachse, Texas, which will be the first to implement PlasmaCap EBA technology at scale. With a dedicated team of approximately 28 employees, Evolve Biologics is actively working towards full commercialization of its products.